- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04376242
Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge
July 11, 2023 updated by: Sayantani B. Sindher, Stanford University
The Utilization of Virtual Reality Technology Versus Standard of Care During Pediatric Oral Food Challenge: A Pilot Study
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care of utilizing existing technologies that are currently more common in food allergy research treatment and clinics (i.e.
television and patients' personal electronic devices) for decreasing levels anxiety and fear in pediatric patients undergoing oral food challenge (OFC) and their caregivers.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94304
- Recruiting
- Stanford University
-
Contact:
- Study Team
- Phone Number: 650-521-7237
- Email: snpcenterallergy_inquiry@stanford.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 17 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Between the ages of 5 and 17
- Willing to participate in both the VR and standard of care technology conditions
- Able to consent or have parental consent
- Undergoing at least two Oral Food Challenges within the window of recruitment at the Sean N. Parker Center
Exclusion Criteria:
- People who do not consent
- Significant Cognitive Impairment
- History of Severe Motion Sickness
- Current Nausea
- Seizures
- Visual Problems
- Non-English Speaking
- Patients who clinically unstable or requires urgent/emergent intervention
- ASA class 4 or higher
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: virtual reality then standard technology
patients randomized to this arm will first use virtual reality (VR) during and oral food challenge and then use standard technology during a second oral food challenge
|
The intervention is a virtual reality program designed to immerse participants in a gaming experience to improve anxiety and fear during an oral food challenge.
the active comparator group will be allowed standard technology for distraction during oral food challenge which can include TV, non-VR gaming, tablets and smart phones.
|
Active Comparator: standard technology then virtual reality
patients randomized to this arm will first use standard technology during and oral food challenge and then use virtual reality during a second oral food challenge
|
The intervention is a virtual reality program designed to immerse participants in a gaming experience to improve anxiety and fear during an oral food challenge.
the active comparator group will be allowed standard technology for distraction during oral food challenge which can include TV, non-VR gaming, tablets and smart phones.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Children's Fear Scale Score Before and After OFC dosing
Time Frame: measurements occur at single time points before and after each food challenge with approximately 4-6 hours between measurements. Thus 4 discrete measurements will be taken over two food challenges which will occur approximately one week apart.
|
The Children's Fear Scale (CFS) is used to measure the anxiety or fear level of the children.
The one-item scale consists of a row of five sex neutral faces ranging from a no fear (neutral) face on the far left to a face showing extreme fear on the far right.
|
measurements occur at single time points before and after each food challenge with approximately 4-6 hours between measurements. Thus 4 discrete measurements will be taken over two food challenges which will occur approximately one week apart.
|
Change in Childhood Anxiety Meter Score Before and After OFC dosing
Time Frame: Before and after each evaluation (approximately 4-6 hours between measurements at each visit, with visits approximately 1 week apart)
|
The Childhood Anxiety Meter brief measure of the current level of anxiety in a child using a visual scale (thermometer that is colored to the level anxiety, higher thermometer level means more anxiety).
|
Before and after each evaluation (approximately 4-6 hours between measurements at each visit, with visits approximately 1 week apart)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of Immersion after OFC
Time Frame: After each evaluation (approximately 1 week apart)
|
Modified scale to assess cognitive absorption as a measure of immersion in the technology.
|
After each evaluation (approximately 1 week apart)
|
Level of satisfaction - participant, caregiver and provider
Time Frame: After each evaluation (approximately 1 week apart)
|
Patient, caregiver and provider satisfaction after dosing will be assessed through a custom satisfaction evaluation form, with categorical responses to questions tailored to specific challenges during OFC such as the time it takes to administer a dose, how well a patient complies with dosing, and how available technology may influence patient and caregiver desire to continue with a study.
|
After each evaluation (approximately 1 week apart)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sayantani Sindher, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Estimated)
September 30, 2024
Study Completion (Estimated)
September 30, 2024
Study Registration Dates
First Submitted
April 29, 2020
First Submitted That Met QC Criteria
May 1, 2020
First Posted (Actual)
May 6, 2020
Study Record Updates
Last Update Posted (Actual)
July 13, 2023
Last Update Submitted That Met QC Criteria
July 11, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 56108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No plan to share.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Allergy
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Chinese University of Hong KongRecruiting
-
King's College LondonKing's College Hospital NHS Trust; University College London Hospitals; Cambridge... and other collaboratorsRecruitingEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustUnknownEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
University Hospital, MontpellierUnknownFood Allergy Suspected | Food Allergy ProvedFrance
-
Rhode Island HospitalCompletedFood Allergy in Children
-
Rhode Island HospitalVirtually Better, Inc.CompletedFood Allergy in Children
Clinical Trials on use of virtual reality
-
Centre Francois BaclesseRecruitingThyroid Cancer | ThyroidectomyFrance
-
Trakya UniversityCompletedPain, Postoperative | Patient Satisfaction | Thyroidectomy | Nursing | Patient ComfortTurkey
-
Assistance Publique - Hôpitaux de ParisVR 4 GOODRecruitingPain, Postoperative | Colon Tumor, Malignant | Rectum TumorFrance
-
Center for Blood and Tissues IV and V Region, ChileUnknown
-
Chi-Ming HuangUMKC School of MedicineNot yet recruitingConcussion | Head Injury Trauma
-
National Taiwan University HospitalRecruiting
-
University of Maryland, BaltimoreNational Center for Advancing Translational Sciences (NCATS); University of...CompletedTrauma | Traumatic Brain Injury | Pain, Acute | Headaches PosttraumaticUnited States
-
University of SevilleInstituto para el Estudio de la Biología de la Reproducción HumanaRecruitingPassive-Aggressive Personality DisorderSpain
-
Central Institute of Mental Health, MannheimGerman Research FoundationWithdrawnLoneliness | Life Change EventsGermany
-
University of MichiganCompleted